Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification.

Oakes BL, Fellmann C, Rishi H, Taylor KL, Ren SM, Nadler DC, Yokoo R, Arkin AP, Doudna JA, Savage DF.

Cell. 2019 Jan 10;176(1-2):254-267.e16. doi: 10.1016/j.cell.2018.11.052.

PMID:
30633905
2.

An open-hardware platform for optogenetics and photobiology.

Gerhardt KP, Olson EJ, Castillo-Hair SM, Hartsough LA, Landry BP, Ekness F, Yokoo R, Gomez EJ, Ramakrishnan P, Suh J, Savage DF, Tabor JJ.

Sci Rep. 2016 Nov 2;6:35363. doi: 10.1038/srep35363.

3.

Biofuel metabolic engineering with biosensors.

Morgan SA, Nadler DC, Yokoo R, Savage DF.

Curr Opin Chem Biol. 2016 Dec;35:150-158. doi: 10.1016/j.cbpa.2016.09.020. Epub 2016 Oct 18. Review.

4.

Live-cell imaging of cyanobacteria.

Yokoo R, Hood RD, Savage DF.

Photosynth Res. 2015 Oct;126(1):33-46. doi: 10.1007/s11120-014-0049-x. Epub 2014 Nov 4. Review.

PMID:
25366827
5.

DNA helicase HIM-6/BLM both promotes MutSĪ³-dependent crossovers and antagonizes MutSĪ³-independent interhomolog associations during caenorhabditis elegans meiosis.

Schvarzstein M, Pattabiraman D, Libuda DE, Ramadugu A, Tam A, Martinez-Perez E, Roelens B, Zawadzki KA, Yokoo R, Rosu S, Severson AF, Meyer BJ, Nabeshima K, Villeneuve AM.

Genetics. 2014 Sep;198(1):193-207. doi: 10.1534/genetics.114.161513. Epub 2014 Jul 21.

6.

Mammalian CNTD1 is critical for meiotic crossover maturation and deselection of excess precrossover sites.

Holloway JK, Sun X, Yokoo R, Villeneuve AM, Cohen PE.

J Cell Biol. 2014 Jun 9;205(5):633-41. doi: 10.1083/jcb.201401122. Epub 2014 Jun 2.

7.

COSA-1 reveals robust homeostasis and separable licensing and reinforcement steps governing meiotic crossovers.

Yokoo R, Zawadzki KA, Nabeshima K, Drake M, Arur S, Villeneuve AM.

Cell. 2012 Mar 30;149(1):75-87. doi: 10.1016/j.cell.2012.01.052.

8.

Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways.

Hua F, Hautaniemi S, Yokoo R, Lauffenburger DA.

J R Soc Interface. 2006 Aug 22;3(9):515-26.

9.

Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis.

Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH, Barbieri E, Rocco I, Garuti A, Wesselborg S, Belka C, Brossart P, Patrone F, Ballestrero A.

Blood. 2005 Apr 15;105(8):3255-62. Epub 2004 Dec 21.

10.

Fibroblast contractile force is independent of the stiffness which resists the contraction.

Freyman TM, Yannas IV, Yokoo R, Gibson LJ.

Exp Cell Res. 2002 Jan 15;272(2):153-62.

PMID:
11777340
11.

Fibroblast contraction of a collagen-GAG matrix.

Freyman TM, Yannas IV, Yokoo R, Gibson LJ.

Biomaterials. 2001 Nov;22(21):2883-91.

PMID:
11561894
12.

Micromechanics of fibroblast contraction of a collagen-GAG matrix.

Freyman TM, Yannas IV, Pek YS, Yokoo R, Gibson LJ.

Exp Cell Res. 2001 Sep 10;269(1):140-53.

PMID:
11525647
13.

Prognostic status of p53 gene mutation in canine mammary carcinoma.

Wakui S, Muto T, Yokoo K, Yokoo R, Takahashi H, Masaoka T, Hano H, Furusato M.

Anticancer Res. 2001 Jan-Feb;21(1B):611-6.

PMID:
11299814

Supplemental Content

Support Center